![]()
|
|
||||||||
J. Biol. Chem., Vol. 261, Issue 31, 14587-14592, Nov, 1986
T Wiedmer, CT Esmon and PJ Sims
Membrane assembly of complement proteins C5b-9 on human platelets results
in a dose-dependent increase in the binding of coagulation factors Va and
Xa to the plasma membrane, concomitant with a marked increase in platelet
prothrombinase activity. Factor Va binding increased by 6-15-fold in
platelets treated with the C5b-9 proteins as compared to controls. In the
presence of near-saturating concentrations of factor Xa, factor Va binding
to C5b-9-treated platelets approximately doubled. In the absence of added
factor Va, C5b-9-treated platelets bound 1700 molecules of factor Xa versus
50 molecules/cell bound to controls, suggesting that C5b-9 assembly on the
platelet surface initiates the release of platelet factor V from the alpha-
granules. The capacity of the C5b-9 proteins to initiate the nonlytic
release of the platelet alpha-granule storage pool was confirmed by assay
for platelet factor 4. When measured in the presence of exogenous factor Va
(2 micrograms/ml), factor Xa uptake by C5b-9 platelets increased to
approximately 5500 molecules/cell (versus 330 molecules/cell for controls).
Removal of external Ca2+ inhibited the C5b-9-initiated release of the
alpha-granule storage pool and reduced by approximately 50% the expression
of new factor Va binding sites, suggesting that these two events
contributing to increased platelet prothrombinase activity are mediated in
part by the influx of Ca2+ across the C5b-9 pore.
On the mechanism by which complement proteins C5b-9 increase platelet prothrombinase activity
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
I. del Conde, M. A. Cruz, H. Zhang, J. A. Lopez, and V. Afshar-Kharghan Platelet activation leads to activation and propagation of the complement system J. Exp. Med., March 21, 2005; 201(6): 871 - 879. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Mojcik and J. H. Levy Aprotinin and the systemic inflammatory response after cardiopulmonary bypass Ann. Thorac. Surg., February 1, 2001; 71(2): 745 - 754. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Rinder, H. M. Rinder, M. J. Smith, J. B. Tracey, J. Fitch, L. Li, S. A. Rollins, and B. R. Smith SELECTIVE BLOCKADE OF MEMBRANE ATTACK COMPLEX FORMATION DURING SIMULATED EXTRACORPOREAL CIRCULATION INHIBITS PLATELET BUT NOT LEUKOCYTE ACTIVATION J. Thorac. Cardiovasc. Surg., September 1, 1999; 118(3): 460 - 466. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sawada, H. Yanamoto, I. Nagata, N. Hashimoto, I. Nakahara, Y. Akiyama, H. Kikuchi, and R. L. Macdonald Prevention of Neointimal Formation by a Serine Protease Inhibitor, FUT-175, After Carotid Balloon Injury in Rats • Editorial Comment Stroke, March 1, 1999; 30(3): 644 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Jansen, B. Eisele, I. W. de Jong, A. Chang, U. Delvos, F. B. Taylor Jr., and C. E. Hack Effect of C1 Inhibitor on Inflammatory and Physiologic Response Patterns in Primates Suffering from Lethal Septic Shock J. Immunol., January 1, 1998; 160(1): 475 - 484. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |